Position in OCGN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$24,846,217
+$17,561,055 QoQ
Shares Held
13,727,192
+154.4% QoQ
Ownership
4.06%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OCGN Over Time
Shares Held
Position Value (USD)
Derivatives in OCGN
reported options exposure · as of Mar 31, 2026CallValue
$371,050
CallShares
205,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026MILLENNIUM MANAGEMENT LLC holds $3,883,849,282 across 342 Biotechnology names. OCGN ranks #38 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JAZZ |
Jazz Pharmaceuticals plc
|
1,262,511 | $238,677,704 | |
| 2 | INSM |
INSMED Inc
|
1,157,786 | $189,321,166 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
3,010,308 | $170,052,298 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
447,887 | $148,192,371 | |
| 5 | ARDX |
Ardelyx, Inc.
|
17,842,370 | $106,875,796 | |
| 6 | BLTE |
Belite Bio, Inc
|
570,088 | $90,894,830 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
1,051,506 | $78,957,585 | |
| 8 | ABVX |
Abivax S.A.
|
605,992 | $67,477,209 |
All Filings in OCGN
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-04-09 | $31,929,472 | 17,074,584 | Shares | Sole | 2026-04-14 | |
| 2026-03-31 | $24,846,217 | 13,727,192 | Shares | Sole | 2026-05-15 | |
| 2026-03-31 | $371,050 | 205,000 | Call | Sole | 2026-05-15 | |
| 2025-12-31 | $7,285,162 | 5,396,417 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $6,784,302 | 4,162,149 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $4,907,158 | 5,058,926 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $57,403 | 81,308 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $137,954 | 171,372 | Shares | Sole | 2025-02-14 | |
| 2024-03-31 | $3,158,238 | 1,925,755 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $236,303 | 410,963 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $649,731 | 1,624,329 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,637,979 | 3,016,537 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,081,332 | 1,267,682 | Shares | Sole | 2023-05-15 | |
| 2022-09-30 | $444,782 | 249,878 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $351,981 | 155,058 | Shares | Sole | 2022-08-15 | |
| 2021-12-31 | $2,089,214 | 459,168 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $152,539 | 21,245 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $4,266,491 | 531,319 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $2,096,881 | 308,819 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||